Evidence map›Paper›PMID 41978654›Full record

ArticleGlobal cardiology science & practice2025

The prevalence of arterial hypertension in Morocco: Screening results from 'May Measurement Month' 2024.

Nora Taiek, Abderrahmane Belkacem, Faiza Aziouaz, Abdelkader Jalil El Hangouche

Abstract read
In one paragraph

Article in Global cardiology science & practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nora TaiekDepartment of Physiology, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaâdi University.
Abderrahmane BelkacemDepartment of Physiology, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaâdi University.
Faiza AziouazDepartment of Physiology, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaâdi University.
Abdelkader Jalil El HangoucheDepartment of Physiology, Faculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaâdi University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArterial hypertension is the leading cause of mortality worldwide. The International Society of Hypertension initiated an annual global initiative called the May Measurement Month screening campaign to raise awareness regarding arterial hypertension and its adverse outcomes.

aimTo evaluate the prevalence of arterial hypertension in Morocco, as well as the prevalence of uncontrolled and untreated hypertension.

methodsAdult participants (≥18 years) were screened through opportunistic sampling across Morocco during May 2024. Trained volunteers recorded standardized blood pressure measurements, with the last two readings being averaged from community volunteer participants, along with socio-demographic parameters, weight, height, lifestyle factors, and comorbidities. Hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg and/or taking antihypertensive medication.

resultsA total of 1421 participants were screened in May 2024, comprising 727 (51,2%) females and 694 (48,8%) males with a median age of 48 years (SD 20.1). Of all 1421 participants, 524 (36.9%) were hypertensive, while 52.9% were unaware of their hypertension status. Among participants who were previously diagnosed with hypertension, 79.4% were on antihypertensive medication, and only 45,9% had controlled hypertension.

conclusionOur study registered a high prevalence of arterial hypertension in Morocco. It also pointed to a high burden of undiagnosed and uncontrolled hypertension.

Identifiers

PMID41978654
PMCPMC13070250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.